Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity.


Por: Rodríguez-Morató J, Goday A, Langohr K, Pujadas M, Civit E, Pérez-Mañá C, Papaseit E, Ramon JM, Benaiges D, Castañer O, Farré M and de la Torre R

Publicada: 31 dic 2019 Ahead of Print: 31 dic 2019
Categoría: Multidisciplinary

Resumen:
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery.

Filiaciones:
Rodríguez-Morató J:
 Department of Experimental and Health Sciences, Universitat Pompeu Fabra (CEXS-UPF), Dr. Aiguader 80, Barcelona, 08003, Spain

 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

 Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain

Goday A:
 Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain

 Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain

 Department of Medicine, Autonomous University of Barcelona, Cerdanyola, Spain

 Cardiovascular Risk and Nutrition Research Group, IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

Langohr K:
 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

 Department of Statistics and Operations Research, Polytechnic University of Catalonia, Barcelona, Spain

Pujadas M:
 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

 Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain

Civit E:
 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

Pérez-Mañá C:
 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

 Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Cerdanyola, Spain

 Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTP-IGTP), Badalona, Spain

:
 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

 Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Cerdanyola, Spain

 Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTP-IGTP), Badalona, Spain

Ramon JM:
 Section of Gastrointestinal Surgery, Hospital del Mar, Barcelona, Spain

Benaiges D:
 Department of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain

 Department of Medicine, Autonomous University of Barcelona, Cerdanyola, Spain

 Cardiovascular Risk and Nutrition Research Group, IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

Castañer O:
 Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain

 Cardiovascular Risk and Nutrition Research Group, IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

:
 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain

 Department of Pharmacology, Therapeutics and Toxicology, Autonomous University of Barcelona, Cerdanyola, Spain

 Clinical Pharmacology Unit, Hospital Universitari Germans Trias i Pujol (HUGTP-IGTP), Badalona, Spain

de la Torre R:
 Department of Experimental and Health Sciences, Universitat Pompeu Fabra (CEXS-UPF), Dr. Aiguader 80, Barcelona, 08003, Spain.

 Integrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program. IMIM (Hospital del Mar Medical Research Institute), Dr. Aiguader 88, Barcelona, 08003, Spain.

 Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain.
ISSN: 20452322





Scientific Reports
Editorial
Nature Publishing Group, HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY, Reino Unido
Tipo de documento: Article
Volumen: 9 Número: 1
Páginas: 20405-20405
WOS Id: 000508985300026
ID de PubMed: 31892725
imagen Green Published, gold

MÉTRICAS